Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
MousePhenoabnormal mammary gland epithelium physiology

ROBO1 STAT6

7.21e-052382MP:0010172
DomainGAGE

GAGE12H GAGE2A GAGE1 GAGE4 GAGE13 GAGE12F GAGE12I GAGE2E GAGE12J

1.58e-2224199PF05831
DomainGAGE_fam

GAGE12H GAGE2A GAGE1 GAGE4 GAGE13 GAGE12F GAGE12I GAGE2E GAGE12J

2.46e-2225199IPR008625
DomainGAGE

GAGE12H GAGE2A GAGE1 GAGE4 GAGE12F

7.08e-1219195SM01379
DomainGAGE

GAGE12H GAGE2A GAGE1 GAGE4 GAGE12F

7.08e-1219195IPR031320
Domainfn3

ROBO1 CMYA5

1.16e-02162192PF00041
DomainFN3

ROBO1 CMYA5

1.49e-02185192SM00060
DomainFN3

ROBO1 CMYA5

1.71e-02199192PS50853
DomainFN3_dom

ROBO1 CMYA5

1.88e-02209192IPR003961
Pubmed

An overview of the GAGE cancer/testis antigen family with the inclusion of newly identified members.

GAGE2B GAGE10 GAGE12H GAGE1 GAGE4 GAGE13 GAGE7 GAGE12F GAGE12I GAGE2E GAGE12J

1.01e-3120231118179644
Pubmed

A Genome-Wide CRISPR Screen Identifies Genes Critical for Resistance to FLT3 Inhibitor AC220.

GAGE2B GAGE10 GAGE1 GAGE13 GAGE7 GAGE12G GAGE12F GAGE12I GAGE2E GAGE12J

1.65e-19119231028625976
Pubmed

A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma.

GAGE2B GAGE2A GAGE1 GAGE4 GAGE12I

9.98e-1592357544395
Pubmed

Isolation and characterization of PAGE-1 and GAGE-7. New genes expressed in the LNCaP prostate cancer progression model that share homology with melanoma-associated antigens.

GAGE1 GAGE4 GAGE7 GAGE12I GAGE2E

2.00e-14102359651357
Pubmed

Characterization of the GAGE genes that are expressed in various human cancers and in normal testis.

GAGE1 GAGE4 GAGE7 GAGE12I GAGE2E

3.66e-141123510397259
Pubmed

The DNA sequence of the human X chromosome.

GAGE2B GAGE10 GAGE12H GAGE2A GAGE13 GAGE7 GAGE12I GAGE2E GAGE12J

2.66e-1240723915772651
Pubmed

GAGE7B promotes tumor metastasis and growth via activating the p38δ/pMAPKAPK2/pHSP27 pathway in gastric cancer.

GAGE12F GAGE12I

4.18e-07223230871606
InteractionFLT3 interactions

GAGE2B GAGE10 GAGE1 GAGE13 GAGE7 GAGE12G GAGE12F GAGE12I GAGE2E NUP205 GAGE12J

1.88e-153182011int:FLT3
InteractionGMCL1 interactions

GAGE10 CFAP298 GAGE2A GAGE1 GAGE12G GAGE12I GAGE2E GAGE12J

1.13e-12154208int:GMCL1
InteractionGAGE12G interactions

GAGE12G GAGE2E

1.96e-057202int:GAGE12G
InteractionEXOC3L2 interactions

GAGE12G GAGE2E

8.45e-0514202int:EXOC3L2
CytobandXp11.23

GAGE2B GAGE12H GAGE2A GAGE1 GAGE13 GAGE12G GAGE12F GAGE12I GAGE2E GAGE12J

9.88e-22952310Xp11.23
CytobandEnsembl 112 genes in cytogenetic band chrXp11

GAGE10 GAGE12H GAGE2A GAGE1 GAGE13 GAGE12G GAGE12F GAGE2E GAGE12J

1.14e-13377239chrXp11
CytobandXp11.4-p11.2

GAGE4 GAGE7

3.60e-066232Xp11.4-p11.2
GeneFamilyFibronectin type III domain containing

ROBO1 CMYA5

1.14e-0316062555
CoexpressionSATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER

GAGE1 GAGE12G GAGE12F

2.98e-0647163M11213
CoexpressionRAY_TARGETS_OF_P210_BCR_ABL_FUSION_UP

GAGE12G GAGE12F

4.17e-0516162M16309
CoexpressionDALESSIO_TSA_RESPONSE

GAGE12G GAGE12F

1.13e-0426162M2340
CoexpressionACEVEDO_METHYLATED_IN_LIVER_CANCER_DN

GAGE2A GAGE1 GAGE12G GAGE12F GAGE2E

1.30e-04873165M16009
CoexpressionGSE411_100MIN_VS_400MIN_IL6_STIM_SOCS3_KO_MACROPHAGE_DN

PPCS FAM120B STAT6

2.28e-04200163M5995
CoexpressionSATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2

GAGE1 GAGE12G

3.72e-0447162M9702
CoexpressionSATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER

GAGE12G GAGE12F

3.72e-0447162M5542
DrugFinish

ROBO1 GAGE7 GAGE12I

7.28e-0723183CID000086133
Drug1ct8

GAGE1 GAGE7 GAGE12I GAGE2E

9.07e-06173184CID000444888
DrugIPEM

GAGE7 GAGE12I

1.24e-057182CID000126238
DrugAC1Q6AQ7

GAGE1 GAGE7 GAGE12I GAGE2E

1.26e-05188184CID000005515
Drug2-methyl-2,4-pentanediol

GAGE1 GAGE7 GAGE12I GAGE2E

1.48e-05196184CID000007870
Drughexadecanol

ROBO1 GAGE7 GAGE12I

2.39e-0572183CID000002682
Drug4-thiouracil

GAGE7 GAGE12I

3.88e-0512182CID002734394
Drug4-META

GAGE7 GAGE12I

6.16e-0515182CID000051027
Drug1bn3

GAGE7 GAGE12I

7.97e-0517182CID000001514
Drug1bnn

GAGE7 GAGE12I

1.00e-0419182CID000001604
Drugindene

GAGE1 GAGE4 GAGE2E

1.10e-04120183CID000007219
Drugdialuminum

GAGE7 GAGE12I

1.75e-0425182CID006857644
DrugAC1L9KOK

GAGE7 GAGE12I

2.53e-0430182CID000447287
DrugAl5300

GAGE7 GAGE12I

2.71e-0431182CID000001611
Drugt-MA

GAGE7 GAGE12I

2.89e-0432182CID000011089
DrugAC1O5D5R

GAGE1 GAGE2E

3.07e-0433182CID006482240
Drughafnium

GAGE7 GAGE12I

4.30e-0439182CID000023986
DiseaseCarcinoma, Granular Cell

ROBO1 GAGE1

8.23e-04116112C0205644
DiseaseAdenocarcinoma, Tubular

ROBO1 GAGE1

8.23e-04116112C0205645
DiseaseAdenocarcinoma, Oxyphilic

ROBO1 GAGE1

8.23e-04116112C0205642
DiseaseCarcinoma, Cribriform

ROBO1 GAGE1

8.23e-04116112C0205643
DiseaseAdenocarcinoma, Basal Cell

ROBO1 GAGE1

8.23e-04116112C0205641
DiseaseAdenocarcinoma

ROBO1 GAGE1

8.23e-04116112C0001418

Protein segments in the cluster

PeptideGeneStartEntry
MMEPPKPEPELQRFY

CCDC87

1

Q9NVE4
GMRDPPMFIPTPVDR

NUP205

1601

Q92621
RYVQPPEMIGPMRPE

GAGE1

16

P0DTW1
RYVQPPEMIGPMRPE

GAGE7

16

O76087
RYVQPPEMIGPMRPE

GAGE2E

16

Q4V326
YVEPPEMIGPMRPEQ

GAGE2D;

16

Q9UEU5
YVEPPEMIGPMRPEQ

GAGE2A

16

Q6NT46
MAEMDPVAEFPQPPG

PPCS

1

Q9HAB8
MIVYPMGLPPYDPIR

CFAP298

151

P57076
RYVQPPEMIGPMRPE

GAGE12B;

16

A1L429
RYVQPPEMIGPMRPE

GAGE12F

16

P0CL80
RYVQPPEMIGPMRPE

GAGE12G

16

P0CL81
RYVQPPEMIGPMRPE

GAGE12H

16

A6NDE8
RYVQPPEMIGPMRPE

GAGE12I

16

P0CL82
PYVQPPEMIGPMRPE

GAGE12J

16

A6NER3
YVEPPEMIGPMLPEQ

GAGE10

16

A6NGK3
MEPQPPNVPESEMKY

CMYA5

1226

Q8N3K9
RYVEPPEMIGPMRPE

GAGE13

16

Q4V321
VPMYTGPESRQEVPM

FAM120B

461

Q96EK7
RYVQPPEMIGPMRPE

GAGE4

16

P0DSO3
YVEPPEMIGPMRPEQ

GAGE2B

16

Q13066
SMQLGPDMVPQVYPP

STAT6

681

P42226
DQEMPCPVPPARMYL

ROBO1

1211

Q9Y6N7
MIRGFEAPMAENPPP

ZNF367

1

Q7RTV3
PMDGPPVRIAYMLVV

XYLT2

226

Q9H1B5